3rd Quarter - Amendment

PUBLIC CITIZEN for PUBLIC CITIZEN

Firm
Client
Income
—
Expenses
$75,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report Oct 11, 2023 $75,000 Replaced
3rd Quarter - Amendment (this page) Oct 19, 2023 $75,000 Yes

What was lobbied

8 issue areas, each in the filer's own words, with who lobbied on it and where.

Banking BAN

banker pay reform DF 956, implementation of DF 956, crypto currency legislation, stablecoin and crypto market structure bills, executive compensation reform, arbitration and financial products.

LobbyistCovered position, as disclosed
BARTLETT NAYLOR —
MARTHA PEREZ-PEDEMONTI —

Contacted: Office of the Comptroller of the Currency (OCC); Federal Reserve System; Federal Housing Finance Agency (FHFA); SENATE; Federal Deposit Insurance Corporation (FDIC); Natl Credit Union Administration (NCUA); Natl Economic Council (NEC); HOUSE OF REPRESENTATIVES

Consumer Issues/Safety/Products CSP

ending forced arbitration, product safety, S.2033 - The American Innovation and Choice Online Act, consumer safety, Sunshine in Product Safety Act, Consumer protections in forthcoming artificial intelligence bill, TSA Facial recognition, Circular A-4 comment, Regulatory reform, Stop Settlement Slush Funds Act of 2023, H.R. 788 opposition, Stop Corporate Capture Act, GOOD Act, REINS Act, The Sunshine for Regulatory Decrees and Settlements Act (against); Stop Settlement Slush Funds Act (against): and Ensuring Accountability in Agency Rulemaking Act, H.R. 357 (against).

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —
MATT KENT —
MARTHA PEREZ-PEDEMONTI —
EMILY PETERSON CASSIN —
ELIZABETH SKERRY —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: S. 2033 (118th), H.R. 357 (118th), H.R. 788 (118th)

Financial Institutions/Investments/Securities FIN

Corporate Lobbying Disclosure

LobbyistCovered position, as disclosed
JONATHAN GOLINGER New —
MARTHA PEREZ-PEDEMONTI —

Contacted: Securities & Exchange Commission (SEC); SENATE; HOUSE OF REPRESENTATIVES

Government Issues GOV

Ban congressional stock trading (S 2463/S 1171/HR 1679/HR 2678), consensus bill, Preserve the Office of Congressional Ethics, Transparency in Government Act, FOIA reform, ARTICLE One Act (HR 3988/S 1912), Ban congressional stock trading (HR 1679/HR 2678/S 1171/S 2463), Judicial Ethics and Anti-Corruption Act (HR 3973/S 1908), National Security and Reforms Accountability Act, Protect Our Democracy Act (PODA), Judicial Ethics and Anti-Corruption Act (S 1908/HR 3973), Real Political Ads Act (HR3044, S1596), Supreme Court Ethics Act (HR927, S325)

LobbyistCovered position, as disclosed
JONATHAN GOLINGER New —
SUSAN ELAINE HARLEY —
CRAIG HOLMAN —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE

Bills named: H.R. 3973 (118th), H.R. 927 (118th), H.R. 1679 (118th), H.R. 2678 (118th), H.R. 3044 (118th), H.R. 3988 (118th)

Health Issues HCR

H.R.3421 & S.1655 - Medicare for All

LobbyistCovered position, as disclosed
EAGAN KEMP —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1655 (118th), H.R. 3421 (118th)

Labor Issues/Antitrust/Workplace LBR

heat stress bill, whistleblower

LobbyistCovered position, as disclosed
JULEY FULCHER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

S.1476 Pharmaceutical Research Transparency Act, S.954 Affordable Insulin Now Act, Medicare drug price negotiation implementation; Bayh-Dole royalty-free rights and contractual reasonable pricing conditions, NDAA government owned medical invention licensing, research and development transparency, and other transactions authority justification, pay for delay reform; product hopping reform; citizen petition abuse reform; FDA prescription drug transparency, S.2220 PREVAIL Act; S. 79 Interagency Patent Coordination and Improvement Act; S.142 Preserve Access to Affordable Generics and Biosimilars Act; S.148 Stop STALLING Act; S.150 Affordable Prescriptions for Patients Act, We PAID Act

LobbyistCovered position, as disclosed
STEVEN KNIEVEL —

Contacted: HOUSE OF REPRESENTATIVES; White House Office; SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 148 (118th), S. 1476 (118th), S. 142 (118th), S. 150 (118th), S. 2220 (118th), S. 954 (118th), S. 79 (118th)

Taxation/Internal Revenue Code TAX

tax filing simplification, financial transaction tax, free IRS Direct File tool/tax filing simplification, Wall Street Tax Act, Bright Lines Project Regs, Ways and Means Request for information on nonprofit political activity.

LobbyistCovered position, as disclosed
SUSAN ELAINE HARLEY —
EMILY PETERSON CASSIN —

Contacted: Treasury, Dept of; Internal Revenue Service (IRS); SENATE; HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.